AU6540500A - Retro-inverso peptides derived from interleukin-6 - Google Patents

Retro-inverso peptides derived from interleukin-6

Info

Publication number
AU6540500A
AU6540500A AU65405/00A AU6540500A AU6540500A AU 6540500 A AU6540500 A AU 6540500A AU 65405/00 A AU65405/00 A AU 65405/00A AU 6540500 A AU6540500 A AU 6540500A AU 6540500 A AU6540500 A AU 6540500A
Authority
AU
Australia
Prior art keywords
retro
interleukin
peptides derived
inverso peptides
inverso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65405/00A
Inventor
D. Elliot Parks
David E. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myelos Corp
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of AU6540500A publication Critical patent/AU6540500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU65405/00A 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-6 Abandoned AU6540500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13968799P 1999-06-16 1999-06-16
US60139687 1999-06-16
PCT/US2000/040227 WO2000077033A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-6

Publications (1)

Publication Number Publication Date
AU6540500A true AU6540500A (en) 2001-01-02

Family

ID=22487847

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65405/00A Abandoned AU6540500A (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-6

Country Status (6)

Country Link
EP (1) EP1183267A4 (en)
JP (1) JP4786843B2 (en)
AU (1) AU6540500A (en)
CA (1) CA2376479A1 (en)
IL (3) IL147094A0 (en)
WO (1) WO2000077033A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
WO1998039357A1 (en) * 1997-03-05 1998-09-11 The Regents Of The University Of California Method of alleviating neuropathic pain
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
CA2376479A1 (en) 2000-12-21
EP1183267A1 (en) 2002-03-06
JP2003502343A (en) 2003-01-21
EP1183267A4 (en) 2002-09-18
WO2000077033A1 (en) 2000-12-21
IL147094A0 (en) 2002-08-14
JP4786843B2 (en) 2011-10-05
IL190034A0 (en) 2011-08-01
IL147094A (en) 2011-04-28

Similar Documents

Publication Publication Date Title
AU7358700A (en) Dolastatin peptides
GB9912852D0 (en) Peptides
AU2002252801A1 (en) Peptides derived from colostrinin
AU2973100A (en) Novel agouti and agouti-related peptide analogs
IL150458A0 (en) Novel haptotactic peptides
EP1159288A4 (en) Alpha-conotoxin peptides
EP1147130A4 (en) Alpha-conotoxin peptides
AU5622700A (en) Retro-inverso peptides derived from leukemia inhibitory factor
AU5496500A (en) Retro-inverso peptides derived from interleukin-3
GB9904695D0 (en) Peptide
AU6540500A (en) Retro-inverso peptides derived from interleukin-6
AU1552800A (en) Coupled peptides
IL144376A0 (en) Peptides
GB9908920D0 (en) Peptide
EP1151100A4 (en) Tau-conotoxin peptides
AU2001290317A1 (en) Novel peptides
AU2002328853A1 (en) Carcinoma-related peptides
AUPP841999A0 (en) Novel peptides
AUPP900899A0 (en) Novel peptides
AUPQ387399A0 (en) Peptides
AUPQ305799A0 (en) Peptides
AUPP589498A0 (en) Novel peptides
AUPP298998A0 (en) Novel peptides
AUPQ591200A0 (en) Novel peptides
AUPP651598A0 (en) Peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase